• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

HCV-infected kidney donors could save lives

byCaitlyn HuiandDeepti Shroff Karhade
March 8, 2018
in Chronic Disease, Infectious Disease, Nephrology, Public Health, Surgery, Urology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. No HCV infection was detected in patients receiving HCV-infected kidneys 12 weeks following treatment.

2. No antiviral treatment-related complications occurred recipients of HCV-infected kidneys.

Evidence Rating Level: 2 (Good)

Study Rundown: Kidney failure and end-stage kidney disease result in significant morbidity and mortality. While kidney transplant is a viable solution for patients with kidney failure, there is a severe shortage of transplant organs. HCV-infected organs from deceased donors are often discarded. The authors of this study aimed to assess the tolerability and feasibility of using direct-acting antivirals (DAAs) in patients receiving kidney transplants from HCV-infected donors to prevent transmission of HCV to donor recipients. It was found that using DAAs resulted in safe pre- and post-kidney transplant. HCV infection was prevented in the recipients of the HCV-infected kidneys as well. Limitations of this study included nonrandomization in the cohort and the study being conducted in a single centre. Furthermore, the number of patients included in the study was small. Overall, the results of the study suggest that with appropriate antiviral prophylaxis, HCV-infected kidneys may be safe to utilize for transplantation for end-stage kidney disease.

Click to read the study in Annals of Internal Medicine

Relevant Reading: Kidney transplantation from an anti-hepatitis C virus antibody-positive donor into an anti-hepatitis C virus antibody-negative recipient: A case report

In-Depth [prospective cohort]: The authors conducted an open-label non-randomized trial involving 10 HCV-negative patients that received a kidney from an HCV-positive donor. All patients received DAA before and after transplant, with the specific antiviral regimen depending on the HCV genotype of the donor. The authors assessed incidence of adverse effects related to DAA treatment, as well as HCV RNA levels in recipients during follow-up. Specifically, HCV RNA was not detected during follow-up meetings after treatment with DAAs. Furthermore, T cell responses did not develop in 7 of the 10 recipients of HCV-infected kidneys, while 3 of the recipients may have developed a T cell response. At the 12 week follow up, 5 of the 10 patients had reactive HCV antibody tests; however, there was no statistically significant association found between donor HCV RNA levels and HCV antibody seroconversion among recipients at week 8 of follow up (p > 0.50). Despite reactive antibody tests, no patients had virologic or clinical evidence of chronic HCV infection at the 12-week follow up.

RELATED REPORTS

Uptake of hepatitis C treatment in people who inject drugs associated with decreased liver disease

Accessible hepatitis C care for people who inject drugs provide significantly higher rates of cure compared to conventional care

Demographic trends associated with increased maternal & neonatal Hepatitis C cases over 10 years

Image: PD

©2018 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: hepatitis Crenal transplant
Previous Post

Collaborative care intervention does not improve health in chronic heart failure, but alleviates depression and fatigue

Next Post

Sexual minorities more likely to become pregnant as teenagers

RelatedReports

Screening insufficient for newborns exposed to hepatitis C virus
Chronic Disease

Uptake of hepatitis C treatment in people who inject drugs associated with decreased liver disease

July 26, 2022
Large spike in drug use-associated infective endocarditis linked with opioid epidemic
Gastroenterology

Accessible hepatitis C care for people who inject drugs provide significantly higher rates of cure compared to conventional care

March 17, 2022
Social networks play key roles in parental vaccination decisions
Chronic Disease

Demographic trends associated with increased maternal & neonatal Hepatitis C cases over 10 years

November 1, 2021
Compliance-linked incentives increase infant immunizations rates in rural India
Infectious Disease

Adenovirus encoding hepatitis C virus vaccine is safe but effectiveness is unclear

February 10, 2021
Next Post
Late gestation antidepressant use linked to postpartum hemorrhage

Sexual minorities more likely to become pregnant as teenagers

Active surveillance in favorable-risk prostate cancer associated with low long-term mortality

Single PSA screening increases prostate cancer detection but does not change mortality

Placebo formulation impacts effectiveness of pain control in osteoarthritis

Opioids show no benefit for treating chronic musculoskeletal pain versus non-opioid treatments

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Endoscopic sleeve gastroscopy effective for excess weight loss in type 1 and 2 obesity
  • #VisualAbstract: Early time-restricted eating was more effective for weight loss than eating over 12-hour window
  • Removal of asymptomatic kidney stones reduces risk of relapse
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.